The recombinant Erythropoietin Market is crucial for treating anemia associated with chronic kidney disease. Recombinant Erythropoietin, also known as epoetin, is manufactured using recombinant DNA technology and stimulates the production of red blood cells. It finds widespread application in chemotherapy, HIV/AIDS treatment, and post-surgery recovery. The Global Recombinant Erythr... https://www.coherentmarketinsights.com/market-insight/recombinant-erythropoietin-market-5960